SCHEMBL7415731

SCHEMBL7415731

O=C(O)CCC(=O)c1cnc(O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
NR4A2 P43354 1/20 0.38
ALDH1A1 P00352 2/20 0.35
CYP2C19 P33261 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.34
FFAR1 O14842 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
EGLN1 Q9GZT9 2/20 0.33
TBXAS1 P24557 2/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
ADAM17 P78536 1/20 0.33
USP5 P45974 1/20 0.33
PIN1 Q13526 1/20 0.33
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18782845 0.76
SCHEMBL23704476 0.66 BAZ2B (0.46)
SCHEMBL18906083 0.61 CTNNB1 (0.68) TSHRNR4A2ALDH1A1CYP2C19GAA
Succinic Acid SCHEMBL156758 0.61
SCHEMBL18906052 0.60 HCAR2 (0.54) TSHRNR4A2ALDH1A1CYP2C19GAA
SCHEMBL31584941 0.58 ALDH1A1 (0.61) TSHRNR4A2ALDH1A1CYP2C19GAA
Succinic Acid SCHEMBL63117 0.58 LMNA (0.82) TSHRNR4A2KMT2ALMNAEGLN1
Succinic Acid SCHEMBL27241854 0.58 LMNA (0.82) TSHRNR4A2KMT2ALMNAEGLN1
Succinic Acid SCHEMBL2353391 0.58 LMNA (0.82) TSHRNR4A2KMT2ALMNAEGLN1
Succinic Acid SCHEMBL1475017 0.58 LMNA (0.82) TSHRNR4A2KMT2ALMNAEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4906630-A Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds RORER PHARMACEUTICAL CORPORATION (US) 1990-03-06 US disclosed
US-4868300-A INOTROPIC AGENTS, CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-09-19 US disclosed
US-4785101-A CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1988-11-15 US disclosed
EP-0247177-A4 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES. RORER INTERNAT OVERSEAS INC (US) 1988-04-06 EP disclosed
US-4725686-A CONGESTIVE HEART FAILURE WILLIAM H. RORER, INC. (US) 1988-02-16 US disclosed
EP-0247177-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1987-12-02 EP disclosed
WO-1987003201-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed